Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3

• Modesto J. Remuiñán ,

  * E-mail: Modesto.b.remuinan@gsk.com

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Esther Pérez-Herrán,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Joaquín Rullás,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Carlos Alemparte,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• María Martínez-Hoyos,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• David J. Dow,

  Affiliation Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom

  ⨯
• Johnson Afari,

  Affiliation Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom

  ⨯
• Nalini Mehta,

  Affiliation Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom

  ⨯
• Jorge Esquivias,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Elena Jiménez,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Fátima Ortega-Muro,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• María Teresa Fraile-Gabaldón,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Vickey L. Spivey,

  Affiliation Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom

  ⨯
• Nicholas J. Loman,

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, United Kingdom

  ⨯
• Mark J. Pallen,

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, United Kingdom

  ⨯
• Chrystala Constantinidou,

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, United Kingdom

  ⨯
• Douglas J. Minick,

  Affiliation Department of Analytical Chemistry, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Mónica Cacho,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• María José Rebollo-López,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Carolina González,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Verónica Sousa,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Iñigo Angulo-Barturen,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Alfonso Mendoza-Losana,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• David Barros,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Gurdyal S. Besra,

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, United Kingdom

  ⨯
• Lluís Ballell,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
•  [ ... ],
• Nicholas Cammack

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• [ view all ]
• [ view less ]